Employer Case Study: Walgreens' Evidence-based Approach to Address High Musculoskeletal Claims and Mental Health

1 out of 2 of your employees likely has a musculoskeletal (MSK) condition such as chronic back or joint pain, which is why MSK claims are consistently a top medical spend driver for employers and health plans. Researchers have uncovered a phenomenon called the “depression-pain dyad” where chronic pain increases the risk for depression and that depression increases the perceived severity of pain - and both conditions need to be addressed for better long-term outcomes. In this webinar:

* Learn how the depression-pain dyad is creating a cycle of pain, isolation, and depression for your workforce

* Understand the rationale and barriers to delivering the expert-recommended three pillars of best practice musculoskeletal care: exercise therapy, behavioral health, and education

* Gain insights into how Walgreens chose and implemented a comprehensive digital musculoskeletal care solution that reduced MSK pain better than opioids, cut depression and anxiety rates by over 60%, and addressed high medical spend by avoiding 2 out of 3 surgeries.


Tom Sondergeld, Vice President Global Health & Mobility, Walgreens Boots Alliance
Dr. Jeff Krauss, M.D., Chief Medical Officer, Hinge Health


Webinar Resources:

Webinar Presentation 

Webinar Recording


David Washington
P: 2025583007

LinkedIn Twitter